Kanda Launches Strategic Partnership with Safe Therapeutics

SafeTherapeutics enables high-performance diagnostic evaluations for patient
conditions by identifying potential adverse drug reactions early on in the care process.
This enhanced level of diagnostic performance facilitates substantially better health
outcomes and patient safety while simultaneously saving time for clinicians and
lowering costs for healthcare organizations.

Kanda will be working alongside Safe Therapeutics to assist in the building of a new pilot platform.